We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Acute Monocytic Leukemia?

By M. Haskins
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Leukemia is a type of cancer that affects the body's ability to produce blood, leading to higher than normal levels of leukocytes, more commonly known as white blood cells. There are many types of leukemia, and acute monocytic leukemia, also called AMoL, specifically affects a certain type of white blood cells called monocytes. Acute monocytic leukemia is a subtype of acute myeloid leukemia, also called AML, which is the most common type of acute leukemia in adults. That it is an acute leukemia means it progresses quickly, with a rapid increase in the number of abnormal white blood cells that inhibit the formation of healthy blood cells in the bone marrow. Acute monocytic leukemia is usually treated with chemotherapy and sometimes bone marrow transplants.

Blood is formed when stem cells in the bone marrow mature into different kinds of blood cells, such as platelets, red blood cells and white blood cells. Healthy white blood cells help the body fight infections, but acute monocytic leukemia causes the formation of more monocytic white blood cells than normal, and because these cells are immature they cannot fight off infection effectively. Their overwhelming number also inhibits the bone marrow's ability to form normal, healthy white blood cells, as well as inhibiting the formation of healthy red blood cells and platelets. Therefore, common symptoms of acute monocytic leukemia are anemia and decreased resistance to infection.

Various classification systems are used to divide these types of cancer of the blood into subcategories. One common classification system used specifically for acute myeloid leukemia includes several subtypes named from M0 to M8. Acute monocytic leukemia belongs to the subtype AML-M5. This subtype is further divided into AML-M5a, which is called acute monoblastic leukemia, and AML-M5b, which is acute monocytic leukemia. Symptoms of both types of AML-M5 leukemia include fatigue, abnormal bruising and bleeding, and increased risk of blood clots in the blood vessels and internal organs.

Hematology is the study of the blood, including how to diagnose, treat, and prevent blood disorders and blood cancers such as acute monocytic leukemia. To diagnose what type of leukemia a patient is suffering from, various blood tests and hematological studies are done, including a complete blood count (CBC) and a white blood cell count (WBC). It is not fully understood what causes any kind of leukemia, but exposure to radiation and some types of chemicals are a risk factor.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.